Espicom Industry View: Malaysia's strategy of introducing business friendly policies and not least a new set of medical device regulations has seen it continue to attract multinational investment in manufacturing plants in the country. Whilst there has been some change, most local manufacturers tend to specialise in the manufacture of rubber-based consumables, which has resulted in a high reliance on imports. This being a factor, alongside continued investments in healthcare, the medical device market is set to expand at a solid 16.1 % per annum.
Headline Industry Forecasts
In US dollar terms, the medical device market is projected to expand by a CAGR of 16.1%, which should see it rise from an estimated US$1,359.0mn in 2013 to US$2,868.6mn in 2018. By major product area, the 2013-2018 CAGRs are expected to range from 24.8% for consumables to 6.5% for dental products.
In US dollar terms, imports grew by 5.9% to reach US$1,173.3mn in 2013. The performance was generally strong in recent years, with a 0.3% growth in 2009 preceding annual growth rates of 18.8%, 15.2% and 18.3% from 2010-2012. The CAGR performance during 2008-2013 was 11.4%. Based on latest collated monthly data, imports to year ending in June 2014 rose by 11.6% over the previous year to reach US$1,231.2mn.
In US dollar terms, exports grew by 19.7% to US$1,707.4mn in 2013, compared with the US$1,426.9mn reported for 2012. In the 2008-2013 period, exports had a CAGR of 13.6%. The value of exports is considerably higher than the value of imports, with a balance of trade surplus of US$534.1mn in 2013. Based on collated monthly data, exports for the year ending in June 2014 rose by 15.0% to reach US$1,819.2mn.
The government has attempted in recent years to encourage domestic manufacturers to expand production into more technologically advanced products but to date the majority still consists of consumables such as rubber gloves and catheters, for which Malaysia is a world leader. More...